LIDDS AB (publ) Share Price Nasdaq Stockholm
Equities
SE0001958612
Biotechnology & Medical Research
Sales 2022 | 1.89M 179K 14.12M | Sales 2023 | - | Capitalization | 7.37M 698K 55.09M |
---|---|---|---|---|---|
Net income 2022 | -36M -3.41M -269M | Net income 2023 | -40M -3.79M -299M | EV / Sales 2022 | 30.5 x |
Net cash position 2022 | 1.26M 120K 9.45M | Net cash position 2023 | 13.51M 1.28M 101M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.58
x | P/E ratio 2023 |
-0.17
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.1% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 30/11/21 | |
Kia Bengtsson
PRN | Corporate Officer/Principal | - | 30/09/22 |
Niklas Axén
PRN | Corporate Officer/Principal | 61 | 31/12/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 01-08 | |
Director/Board Member | 66 | 01-08 | |
Chairman | 48 | 31/12/16 |
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+17.03% | 26.02B | |
-23.86% | 19.39B | |
-19.49% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |